TREA

76682429 - LAILIXIN

Follow

Information

  • Trademark
  • 76682429
  • Serial Number
    76682429
  • Filing Date
    October 01, 2007
    17 years ago
  • Transaction Date
    October 21, 2011
    13 years ago
  • Status Date
    October 20, 2011
    13 years ago
  • Published for Opposition Date
    September 09, 2008
    16 years ago
  • Location Date
    October 20, 2011
    13 years ago
  • First Use Anywhere Date
    July 11, 2008
    16 years ago
  • First Use In Commerce Date
    October 27, 2009
    15 years ago
Information
Mark Drawing Code
3000
Mark Identification
LAILIXIN
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0051: Full line of bulk pharmaceuticals, pharmaceutical intermediates, pharmaceutical preparations, antibiotics for animals and humans, animal feed supplements, human food supplements, herbal supplements for animals and humans, mineral supplements for animals and humans, dietary supplements for animals and humans, and vitamins for animals and humans in the form of caplets, capsules, creams, drops, douches, foams, gel-tabs, gels, inhalants, injectables, lotions, ointments, pastilles, powders, rinses, shampoos, solutions, spansules, sponges, sprays, suppositories, syrups and tablets; Ace-inhibitors; Adrenergic agonists; Adrenergic blockers; Anabolics; Analgesics, narcotic and non-narcotic analgesics; Anesthetics; Antianorexics; Antacids; Anthelmintics; Antiacnes; Antiallergics; Antianginals; Antiarthritics and antirheumatics; Antiasthmatics; Antibacterials; Antibiotics; Anticoagulants; Anticonvulsants; Antidepressants; Antidiabetics; Antidiarrheals; Antidiuretics; Antiemetics; Antifungals; Antiglaucomas; Antihistaminics; Antihypertensives; Antihyperthyroids; Antihypotensives; Anti-inflammatories; Anti-itch creams, ointments and sprays; Antimalarials; Antimigraines; Antimuscarinics; Antineoplastics; Antioxidants; Antiparkinsonians; Antiprotozoals; Antipruritics; Antipsoriatics; Antipsychotics; Antiseborrheics; Antiseptics; Antispasmodics; Antisyphilitics; Antithrombotics; Antitussives; Antiulceratives; Antivirals; Anxiolyties; Astringents; Bacteriostats for medicinal, dental and veterinary use; Bath salts for medical purposes; Beta-blockers; Biocides; Biological and chemical reagents for medical or veterinary use; Bronchodilators; Burn-relief medications; Calcium channel blockers; Cardiotonics; nutritional additives for use in dietary supplements, namely, carotenoids; Chemotherapeutics; Choleretics; Cholesterol reducers; Cholinergics; Cholinesterase inhibitors; Cleansing solutions for medical use; Clinical medical reagents; CNS stimulants; Contraceptives; Decongestants; Dermatologicals; Diagnostic preparations for medical purposes; Dietary and nutritional supplements; Diuretics; Dopamine receptor agonists; Enzyme cofactors; Estrogens; Expectorants; Food supplements; Gastric and pancreatic preparations; Germicides; Glucosidase inhibitors; Gonad-stimulating principles; Hematinics; Hematopoietics; Hemostatics; Hepatoprotectants; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Homeopathic supplements; Immunomodulators; Immunosuppressants; Laxatives; Medicinal herbal extracts; Mineral nutritional supplements; Mineralocorticoids; Mixed vitamin preparations; Mucolytics; Multi-vitamin preparations; Muscle relaxants; Mydriatics; Neutraceuticals for use as dietary supplements; Nootropics; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Plant extracts for medical, veterinary and pharmaceutical purposes; Processed food adapted for medical purposes; Progestogens; Prolactin inhibitors; Prostaglandins and prostaglandin analogs; dietary supplements; Respiratory stimulants; Reverse transcriptase inhibitors; Sedatives; Seratonin receptor agonists and antagonists; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; medicated topical skin protectants for medical use; Vasodilators; Vasoprotectants; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
  • TLIT00: The non-Latin characters in the mark transliterate to "LAI" "LI" and "XIN" and this means "COMING" "STAND" and "LETTER" in English.
  • TR0010: The wording "LAILIXIN" has no meaning in a foreign language.
Case File Event Statements
  • 10/21/2011 - 13 years ago
    45 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 10/20/2011 - 13 years ago
    44 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 3/14/2011 - 13 years ago
    43 - FINAL REFUSAL MAILED Type: CNFR
  • 3/13/2011 - 13 years ago
    42 - SU - FINAL REFUSAL - WRITTEN Type: CNFR
  • 8/12/2010 - 14 years ago
    41 - NON-FINAL ACTION MAILED Type: CNRT
  • 8/11/2010 - 14 years ago
    40 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 7/21/2010 - 14 years ago
    39 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/20/2010 - 14 years ago
    38 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 7/20/2010 - 14 years ago
    37 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/19/2010 - 14 years ago
    36 - PAPER RECEIVED Type: MAIL
  • 7/1/2010 - 14 years ago
    35 - NON-FINAL ACTION MAILED Type: CNRT
  • 6/30/2010 - 14 years ago
    34 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 6/8/2010 - 14 years ago
    33 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 5/19/2010 - 14 years ago
    32 - USE AMENDMENT FILED Type: IUAF
  • 6/5/2010 - 14 years ago
    31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/19/2010 - 14 years ago
    30 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/19/2010 - 14 years ago
    29 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 12/1/2009 - 15 years ago
    28 - EXTENSION 2 GRANTED Type: EX2G
  • 12/1/2009 - 15 years ago
    27 - EXTENSION 2 FILED Type: EXT2
  • 12/1/2009 - 15 years ago
    26 - TEAS EXTENSION RECEIVED Type: EEXT
  • 4/28/2009 - 15 years ago
    25 - EXTENSION 1 GRANTED Type: EX1G
  • 4/28/2009 - 15 years ago
    24 - EXTENSION 1 FILED Type: EXT1
  • 4/28/2009 - 15 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/2/2008 - 16 years ago
    22 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/9/2008 - 16 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/20/2008 - 16 years ago
    20 - NOTICE OF PUBLICATION Type: NPUB
  • 8/5/2008 - 16 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/30/2008 - 16 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/14/2008 - 16 years ago
    17 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 7/14/2008 - 16 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/14/2008 - 16 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/9/2008 - 16 years ago
    14 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 7/9/2008 - 16 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/9/2008 - 16 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/2/2008 - 16 years ago
    11 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/16/2008 - 16 years ago
    10 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 6/16/2008 - 16 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/10/2008 - 16 years ago
    8 - FAX RECEIVED Type: FAXX
  • 6/11/2008 - 16 years ago
    7 - ASSIGNED TO LIE Type: ALIE
  • 6/10/2008 - 16 years ago
    6 - FAX RECEIVED Type: FAXX
  • 1/10/2008 - 17 years ago
    5 - NON-FINAL ACTION MAILED Type: CNRT
  • 1/10/2008 - 17 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/7/2008 - 17 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/13/2007 - 17 years ago
    2 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/9/2007 - 17 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP